SNPX 外汇新闻
Synaptogenix Partners With LSU Health New Orleans To Study PUFA Analogs To Treat Spinal Cord Injury
Biopharmaceutical company Synaptogenix, Inc. (SNPX) announced Thursday a new collaboration agreement with LSU Health New Orleans' Neuroscience Center of Excellence for pre-clinical testing of the Company's polyunsaturated fatty acid (PUFA) analogs as a treatment for spinal cord injury (SCI).
RTTNews
|
103天前
